Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Biologics in the treatment of systemic lupus erythematosus

(2010) Aisha Lateef et al.   CURRENT OPINION IN RHEUMATOLOGY

Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis

(2010) YH Lee et al.   LUPUS

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

(2009) Daniel J. Wallace et al.   ARTHRITIS AND RHEUMATISM

Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial

(2009) Ellen M. Ginzler et al.   ARTHRITIS AND RHEUMATISM

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality

(2009) F Goldblatt et al.   LUPUS

Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not!

(2009) M. Y. Karim et al.   RHEUMATOLOGY

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

(2008) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: Mortality risk and quality of life early in the course of disease

(2008) Robert Campbell et al.   ARTHRITIS AND RHEUMATISM

Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort

(2008) M. B. Urowitz et al.   ARTHRITIS AND RHEUMATISM

Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California

(2008) Arti Parikh-Patel et al.   CANCER CAUSES & CONTROL

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study

(2007) S Bernatsky et al.   ANNALS OF THE RHEUMATIC DISEASES